The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma

Blood

Volumn 123, Issue 25, 2014, Pages 3925-3931

  Cook, Lucy B ^a   Melamed, Anat ^a   Niederer, Heather ^a   Valganon, Mikel ^b   Laydon, Daniel ^a   Foroni, Letizia ^b   Taylor, Graham P ^a   Matsuoka, Masao ^c   Bangham, Charles R M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR; TAX PROTEIN;

ACROCENTRIC CHROMOSOME; ANIMAL CELL; ARTICLE; CELL CLONE; CELL PROLIFERATION; CHROMOSOME 13; CLONAL VARIATION; CONTROLLED STUDY; EXON; EXON 2; EXON 3; GENE FUNCTION; GENE ONTOLOGY; GENE REARRANGEMENT; GENE SEQUENCE; HEMATOLOGIC MALIGNANCY; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; IN VIVO STUDY; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVIRUS; T CELL LEUKEMIA; TRANSCRIPTION INITIATION SITE; VIRAL GENETICS; VIRUS DNA CELL DNA INTERACTION; VIRUS MORPHOLOGY; VIRUS SURVIVAL;

ADULT; ANIMALS; BINDING SITES; CELL LINE; CHROMOSOME MAPPING; CLONE CELLS; COHORT STUDIES; GENE EXPRESSION; GENE ONTOLOGY; GENE PRODUCTS, TAX; GENOME, HUMAN; HOST-PATHOGEN INTERACTIONS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; PROVIRUSES; RATS; T-LYMPHOCYTES; TERMINAL REPEAT SEQUENCES; VIRUS INTEGRATION;

EID: 84902675048     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-02-553602     Document Type: Article

References (29)

1. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991;79(3):428-437.
2. Sasaki D, Doi Y, Hasegawa H, et al. High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disorders. Virol J. 2010;7:81.
3. Iwanaga M, Watanabe T, Utsunomiya A, et al; Joint Study on Predisposing Factors of ATL Development investigators. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010;116(8):1211-1219.
4. Demontis MA, Hilburn S, Taylor GP. Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases. AIDS Res Hum Retroviruses. 2013;29(2):359-364.
5. Overbaugh J, Bangham CR. Selection forces and constraints on retroviral sequence variation. Science. 2001;292(5519):1106-1109. (Pubitemid 32440922)
6. Gillet NA, Malani N, Melamed A, et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood. 2011;117(11):3113-3122.
7. Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CR. HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood. 2012;120(17):3488-3490.
8. Tsukasaki K, Tsushima H, Yamamura M, et al. Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. Blood. 1997;89(3):948-956. (Pubitemid 27121288)
9. Matsuoka M, Jeang KT. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene. 2011;30(12):1379-1389.
10. Bangham CR. CTL quality and the control of human retroviral infections. Eur J Immunol. 2009;39(7):1700-1712.
11. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 1998;4(6):586-593. (Pubitemid 29042065)
12. Jeffery KJ, Usuku K, Hall SE, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA. 1999;96(7):3848-3853. (Pubitemid 29168999)
13. Melamed A, Laydon DJ, Gillet NA, Tanaka Y, Taylor GP, Bangham CR. Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog. 2013;9(3):e1003271.
14. Nosaka K, Maeda M, Tamiya S, Sakai T, Mitsuya H, Matsuoka M. Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia. Cancer Res. 2000;60(4):1043-1048. (Pubitemid 30129543)
15. Kwok S, Ehrlich G, Poiesz B, Kalish R, Sninsky JJ. Enzymatic amplification of HTLV-I viral sequences from peripheral blood mononuclear cells and infected tissues. Blood. 1988;72(4):1117-1123. (Pubitemid 18265868)
16. Tamiya S, Matsuoka M, Etoh K, et al. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood. 1996;88(8):3065-3073. (Pubitemid 26357389)
17. Takeda S, Maeda M, Morikawa S, et al. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer. 2004;109(4):559-567. (Pubitemid 38339647)
18. Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylations in the human genome. Cell. 2007;129(4):823-837. (Pubitemid 46802390)
19. Sadelain M, Papapetrou EP, Bushman FD. Safe harbours for the integration of new DNA in the human genome. Nat Rev Cancer. 2012;12(1):51-58.
20. Laydon DJ, Melamed A, Sim A, et al. Quantification of HTLV-1 clonality and TCR diversity. PLOS Comput Biol. In press.
21. Gini C. Variabilita e Mutuabilita. Contributo allo Studio delle Distribuzioni e delle Relazioni Statistiche. Bologna, Italy: C. Cuppini; 1912.
22. Handcock M, Morris M. Relative Distribution Methods in the Social Sciences. New York, NY: Springer-Verlag; 1999.
23. Presson AP, Kim N, Xiaofei Y, Chen IS, Kim S. Methodology and software to detect viral integration site hot-spots. BMC Bioinformatics. 2011;12:367.
24. Berry CC, Gillet NA, Melamed A, Gormley N, Bangham CR, Bushman FD. Estimating abundances of retroviral insertion sites from DNA fragment length data. Bioinformatics. 2012;28(6):755-762.
25. Meekings KN, Leipzig J, Bushman FD, Taylor GP, Bangham CR. HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog. 2008;4(3):e1000027.
26. Bangham CRM, Cook LB, Melamed A. HTLV-1 clonality in adult T-cell leukaemia and nonmalignant HTLV-1 infection [published online ahead of print December 6, 2013]. Semin Cancer Biol.
27. Melamed A, Witkover AD, Laydon DJ, et al. Clonality of HTLV-2 in natural infection. PLoS Pathog. 2014;10(3):e1004006.
28. Macnamara A, Rowan A, Hilburn S, et al. HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog. 2010;6(9):e1001117.
29. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013;339(6127):1546-1558.